Filing step-change
INDRANIB · 2026-10
Quarterly observations that moved versus the prior period in 2026-10. Facts only — not a call to act.
Narrative date 2026-10-21 · Evidence medium
In a significant shift in the market, INDRANIB saw its 28.05% gross margin accelerate to, up from 0.99%.
Raw Evidence
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 28.05 % | 0.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 0.99 % | 0.51 | ▲ |
| REVENUE_GROWTH_YOY | 27.6 % | 295.3 | ▼ |
Cite this
Source: Samhati filing step-change for INDRANIB (2026-10). Observation: In a significant shift in the market, INDRANIB saw its 28.05% gross margin accelerate to, up from 0.99%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/indranib/q/2026-10
Other periods